Data / Form D filings / Scienture Holdings, Inc.
Scienture Holdings, Inc.: Form D filings
Scienture Holdings, Inc., a pharmaceuticals company in Commack, NY, filed 13 Form D notices with the SEC between 2014 and 2025. The latest, on August 7, 2025, reports $1.7 million sold of a $3 million offering to 8 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 20 AUSTIN BLVD., Commack, NY, 11725
- Phone
- (866) 468-6535
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b), Securities Act section 4(a)(5)
- SEC identifier (CIK)
- 1382574
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 7, 2025 | Amendment | $3,000,000 | $1,715,000 | $1,285,000 | 8 | Jul 18, 2025 | sec.gov |
| Aug 1, 2025 | New notice | $3,000,000 | $1,300,000 | $1,700,000 | 4 | Jul 18, 2025 | sec.gov |
| Dec 19, 2024 | New notice | $3,333,333 | $3,333,333 | 2 | Nov 25, 2024 | sec.gov | |
| Aug 8, 2019 | New notice | $2,000,000 | $1,000,000 | $1,000,000 | 1 | Jul 30, 2019 | sec.gov |
| Nov 14, 2018 | New notice | $1,000,000 | $500,000 | $500,000 | 1 | Nov 13, 2018 | sec.gov |
| Oct 25, 2018 | New notice | $300,000 | $300,000 | 1 | Oct 16, 2018 | sec.gov | |
| Jul 13, 2018 | New notice | $2,000,000 | $300,000 | $1,700,000 | 2 | Jul 11, 2018 | sec.gov |
| Mar 21, 2017 | New notice | $250,875 | $250,875 | 1 | Feb 28, 2017 | sec.gov | |
| Jan 17, 2017 | New notice | $15,000 | $0 | $15,000 | 1 | Dec 31, 2016 | sec.gov |
| Nov 3, 2015 | New notice | $1,505,000 | $451,600 | $1,053,400 | 1 | Oct 22, 2015 | sec.gov |
| Oct 21, 2014 | New notice | $2,000,000 | $1,100,000 | $900,000 | 3 | Oct 16, 2014 | sec.gov |
| Aug 27, 2014 | New notice | $375,000 | $375,000 | 5 | Mar 27, 2014 | sec.gov | |
| Aug 26, 2014 | New notice | $64,900,000 | $64,900,000 | 28 | Jan 8, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Donald G. Fell | Director | |
| Subbarao G. Jayanthi | Director | |
| Shankar Hariharan | Executive Officer, Director | |
| Narasimhan Mani | Executive Officer, Director | |
| Mayur G. Doshi | Director |
Other pharmaceuticals companies in New York that filed recently
- Pierrepont Therapeutics, Inc. $2.4 million · Sep 22, 2026
Every Form D from the week of Aug 4, 2025 · All recent filings in New York · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Scienture Holdings, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.